Dr. Judith Hochman and Dr. Arzu Kalayci: International Study of Comparative Health Effectiveness With Medical and Invasive Approaches: Primary Report of Clinical Outcomes November 17, 2019 Disclosures: TBA
Dr. James A Underberg and Dr. Adam T Phillips Discuss: LDL Lowering Therapies and How They Can Impact ASCVD November 17, 2019 Disclosures: TBA
Dr. Calum MacRae and Dr. C. Michael Gibson Discuss: One Brave Idea – An Update – Sponsored by an independent educational grant from The Medicines Company November 17, 2019 Disclosures: TBA
Dr. Gregg Stone and Dr. C. Michael Gibson Discuss: Deep Dive on ISCHEMIA November 16, 2019 Disclosures: TBA
Dr. Carolyn Lam and Dr. C. Michael Gibson Discuss: Role of AI and Machine Learning in Cardiac Imaging and Beyond November 16, 2019 Disclosures: TBA
Dr. Dean Kereiakes and Dr. C. Michael Gibson Discuss: First Human Study of a Novel Platelet Glycoprotein IIB/IIIA Inhibitor Designed for Point of Care ST-Segment Myocardial Infarction Treatment November 16, 2019 Disclosures: TBA
Dr. John McMurray and Dr. C. Michael Gibson Discuss: DAPA-HF: The Dapagliflozin and Prevention of Adverse-Outcomes in Heart Failure Trial (DAPA-HF): Results in Nondiabetic Patients November 16, 2019 Disclosures: TBA
Dr. Jean Claude-Tardif and Dr. Adam T Phillips Discuss: COLCOT: The COLchicine Cardiovascular Outcomes Trial November 16, 2019 Disclosures: TBA
Dr. Ole De Backer and Dr. C. Michael Gibson Discuss: GALILEO-4D: Randomized Clinical Trial Comparing a Rivaroxaban-Based Strategy With an Antiplatelet-Based Strategy for the Prevention of Subclinical Leaflet Thrombosis in Transcatheter Aortic Valves November 16, 2019 Disclosures: TBA
Dr. Frederick Raal and Dr. C. Michael Gibson Discuss: Phase 3 ORION-9: Safety and Efficacy of Inclisiran in Patients With Heterozygous Familial Hypercholesterolemia – Results From the Phase 3 ORION-9 Trial November 16, 2019 Disclosures: TBA
